Search

everythinglearnresearchcommunity

for

Search:↓

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

CEC levels may be a useful marker for predicting prostate cancer progression.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The study found no common cause for a girl's crystalline cataract and uncombable hair, suggesting their co-occurrence might be coincidental.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

New method quickly and accurately measures finasteride in tablets.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Human hair protein modifications could potentially indicate heart disease risk.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

The gene Prss53 affects hair shape and bone development in rabbits.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Serum triglyceride levels are not linked to prostate cancer risk.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Low iron levels may be linked to some types of hair loss in women.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.